Trewin-Nybråten CB, Lambert PC, Marienhagen K, Andreassen L, Johannesen TB, Niehusmann P, Oltedal L, Schipmann S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Brandal P, Ingebrigtsen T, Skaga E, advisory board for the Norwegian Brain and Spinal Cord Tumour Registry(2025) Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry J Neurooncol(in press) DOI 10.1007/s11060-025-05218-3, PubMed 40932639
Winther RR, Hjermstad MJ, Yri OE, Skovlund E, Aass N, Astrup GL, Kaasa S, Saxhaug C, Vik-Mo EO(2025) Survival, quality of life, and motor function in brain metastases surgery: The role of complete resection Neurooncol Pract, 12(4), 644-653 DOI 10.1093/nop/npaf011, PubMed 40814420
Yuan D, Jugas R, Pokorna P, Sterba J, Slaby O, Schmid S, Siewert C, Osberg B, Capper D, Halldorsson S, Vik-Mo EO, Zeiner PS, Weber KJ, Harter PN, Thomas C, Albers A, Rechsteiner M, Reimann R, Appelt A, Schüller U, Jabareen N, Mackowiak S, Ishaque N, Eils R, Lukassen Set al.(2025) crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumors Nat Cancer, 6(7), 1283-1294 DOI 10.1038/s43018-025-00976-5, PubMed 40481322